27 May, 2017
Consonance Capital Management LP now owns 3,531,487 shares of the biopharmaceutical company's stock worth $127,310,000 after buying an additional 595,000 shares during the last quarter. Finally, Hamilton Lane Advisors LLC bought a new stake in shares of Clovis Oncology during the first quarter worth about $226,000. Vantiv Inc now has $12.42B valuation. About 797,101 shares traded. Clovis Oncology Inc has a 52-week low of $11.57 and a 52-week high of $74.94. It has underperformed by 1.87% the S&P500.
Stuart Weisbrod decreased its stake in Clovis Oncology Inc (CLVS) by 76.92% based on its latest 2016Q4 regulatory filing with the SEC. Bnp Paribas Arbitrage invested in 0% or 2,276 shares.
Iguana Healthcare Management Llc, which manages about $139.00 million and $167.30 million US Long portfolio, upped its stake in Biogen Inc (NASDAQ:BIIB) by 15,000 shares to 35,000 shares, valued at $9.93 million in 2016Q4, according to the filing. BlackRock Advisors LLC increased its position in Clovis Oncology by 203.4% in the third quarter. The stock declined 4.85% or $2.67 reaching $52.37 per share.
About 505,527 shares traded. Consonance Cap Mgmt Limited Partnership stated it has 13.32% of its portfolio in Clovis Oncology Inc (NASDAQ:CLVS). It has outperformed by 266.01% the S&P500. The stock of Clovis Oncology Inc (NASDAQ:CLVS) earned "Buy" rating by Suntrust Robinson on Wednesday, August 24. FMR LLC now owns 1,816,859 shares of the biopharmaceutical company's stock worth $115,679,000 after buying an additional 1,327,703 shares during the last quarter. After having $-1.33 EPS previously, Clovis Oncology Inc's analysts see 3.01 % EPS growth. Two analysts have rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company's stock. Therefore 67% are positive. Clovis Oncology had 32 analyst reports since September 10, 2015 according to SRatingsIntel. The firm has "Neutral" rating given on Monday, January 25 by Mizuho. The stock has "Outperform" rating by Credit Suisse on Wednesday, September 21. Stifel Nicolaus maintained the stock with "Buy" rating in Monday, January 23 report. As per Monday, May 9, the company rating was maintained by WallachBeth Capital. The stock has "Neutral" rating by Mizuho on Monday, November 16. The firm earned "Hold" rating on Tuesday, November 17 by WallachBeth Capital. The company was maintained on Friday, September 23 by Suntrust Robinson. Citigroup has invested 0.01% in Clovis Oncology Inc (NASDAQ:CLVS).
Since March 15, 2017, it had 0 buys, and 2 insider sales for $343,140 activity. The original version of this piece can be viewed at https://transcriptdaily.com/2017/05/27/clovis-oncology-inc-clvs-insider-gillian-c-ivers-read-sells-3000-shares-of-stock-updated.html.
Investors sentiment decreased to 1.03 in Q4 2016. Its down 0.97, from 2 in 2016Q3. It worsened, as 30 investors sold CLVS shares while 48 reduced holdings. Numeric Ltd Limited Liability Company has invested 0.01% in Clovis Oncology Inc (NASDAQ:CLVS). Chicago Equity Lc reported 19,120 shares.
Clovis Oncology, Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other worldwide markets. JPMorgan Chase & Co. reiterated a "hold" rating on shares of Clovis Oncology in a report on Wednesday, March 15th. 82,100 are held by Renaissance Technology Ltd Liability. The biopharmaceutical company reported ($1.33) earnings per share for the quarter, beating analysts' consensus estimates of ($1.43) by $0.10. Healthcor Mgmt Lp holds 1.57% or 625,000 shares. Cornerstone Cap Mgmt Ltd Llc invested in 1,200 shares. Metropolitan Life Insurance owns 23,566 shares.
Clovis Oncology (NASDAQ:CLVS) last posted its quarterly earnings data on Wednesday, May 3rd. Vanguard Group Inc. now owns 3,285,195 shares of the biopharmaceutical company's stock worth $209,169,000 after buying an additional 662,969 shares during the last quarter. Stifel Corp has 0% invested in Clovis Oncology Inc (NASDAQ:CLVS). Focused Wealth Mngmt owns 2,215 shares. Partner Fund Mngmt Limited Partnership holds 1.28M shares. Premier Inc (NASDAQ:PINC) was reduced too.
Investors sentiment increased to 0.98 in Q4 2016. Its up 0.02, from 1.12 in 2016Q3. 74 funds opened positions while 143 raised stakes. State Street reported 2.14 million shares stake. Lucus Advsrs Ltd Limited Liability Company owns 17,489 shares. Dekabank Deutsche Girozentrale holds 0.01% or 24,700 shares in its portfolio. (NASDAQ:SPLS). Tudor Corporation Et Al reported 0.06% stake. Moreover, Freestone Capital has 0% invested in Staples, Inc. Alyeska Gp Lp stated it has 0.63% of its portfolio in Vantiv Inc (NYSE:VNTV). State Board Of Administration Of Florida Retirement Systems invested in 0% or 21,979 shares. (NASDAQ:SPLS). Commonwealth Of Pennsylvania Pub School Empls Retrmt has invested 0.01% in Staples, Inc. Ameritas Prtn Inc has invested 0.01% in Staples, Inc. National Bank & Trust Of Montreal Can accumulated 12,502 shares or 0% of the stock.
The stock of Finjan Holdings, Inc. Topeka Capital Markets downgraded the shares of VNTV in report on Thursday, October 29 to "Hold" rating. As per Friday, July 29, the company rating was downgraded by CLSA. The firm has "Overweight" rating by PiperJaffray given on Thursday, January 26. Piper Jaffray Companies set a $77.00 price objective on Clovis Oncology and gave the company a "buy" rating in a research note on Tuesday, March 28th.
